All Stories

  1. An EACVI survey assessing the awareness of cardiovascular imaging's environmental impact among cardiovascular imagers
  2. European Association of Cardiovascular Imaging survey on imaging for myocardial viability
  3. EACVI survey on evaluation and quantification of aortic regurgitation by multi-modality imaging
  4. Asymptomatic severe degenerative mitral regurgitation
  5. Identification and characterization of necrotic tumour using contrast-enhanced echocardiography
  6. High-definition blood flow imaging improves quantification of left ventricular volumes and ejection fraction
  7. Determinants of post-operative left ventricular dysfunction in degenerative mitral regurgitation
  8. Usefulness of contrast enhanced cardiac ultrasound to assess vascularity in cardiac mass of unknown aetiology
  9. Care of the patient after valve intervention
  10. Mitral regurgitation management: a systematic review of clinical practice guidelines and recommendations
  11. Blood biomarkers in patients with repaired Tetralogy of Fallot (rTOF); A systematic review and meta-analysis
  12. Vaccine-induced immune thrombocytopenia and thrombosis associated anterior ST-elevation myocardial infarction
  13. Moderate Aortic Stenosis: What is it and When Should We Intervene?
  14. Incidence of Cabergoline-Associated Valvulopathy in Primary Care Patients With Prolactinoma Using Hard Cardiac Endpoints
  15. Association between mitral annular calcification and progression of mitral and aortic stenoses
  16. Racial differences in the aetiology of mitral valve disease
  17. Mortality Whilst Waiting For Intervention In Symptomatic Severe Aortic Stenosis
  18. ‘Valvular’ AL amyloidosis
  19. Inconsistency in aortic stenosis severity between CT and echocardiography: prevalence and insights into mechanistic differences using computational fluid dynamics
  20. Mitral valve prolapse
  21. Stress echocardiography in valvular heart disease
  22. Does presence of left ventricular contractile reserve improve response to cardiac resynchronization therapy? An updated meta-analysis
  23. Classification of Aortic Stenosis by Flow and Gradient Patterns Provides Insights into the Pathophysiology of Disease
  24. Disintegration of polyvinyl alcohol membrane covering atrial septal defect closure device:
  25. Dynamic Mitral Regurgitation
  26. Prevalence & composition of heart valve multi-disciplinary teams within a national health system
  27. Comprehensive assessment of complications of infective endocarditis by 3D transesophageal echocardiography
  28. The Feasibility and Clinical Utility of Myocardial Contrast Echocardiography in Clinical Practice: Results from the Incorporation of Myocardial Perfusion Assessment into Clinical Testing with Stress Echocardiography Study
  29. SIMULTANEOUS MYOCARDIAL PERFUSION ASSESSMENT DURING MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY PROVIDES INCREMENTAL PROGNOSTIC VALUE BEYOND WALL MOTION ANALYSIS WHEN INCORPORATED INTO A REAL-WORLD CLINICAL STRESS ECHOCARDIOGRAPHY SERVICE
  30. Development of a National Echocardiography Quality Improvement Programme: insights into feasibility, uptake, and clinical utility
  31. Comprehensive cardiovascular MRI in hypertension: a UK single centre experience
  32. Cardiac tumors: the role of cardiovascular imaging
  33. Clinical Utility and Prognostic Value of Appropriateness Criteria in Stress Echocardiography for the Evaluation of Valvular Heart Disease
  34. Cardiac manifestations of gastrointestinal carcinoid tumor
  35. Characterisation of left ventricular myocardial fibrosis in adult congenital heart disease by contrast and deformation echocardiography validated by CMR
  36. Characterisation of intra-cardiac masses by myocardial contrast echocardiography
  37. Outcomes, risks and complications of cardiac surgery for carcinoid heart disease
  38. Risk Factors for the Development and Progression of Carcinoid Heart Disease
  39. Surgery for carcinoid heart disease: current outcomes, concerns and controversies
  40. Drug-induced fibrotic valvular heart disease
  41. A stepwise approach to the management of metastatic midgut carcinoid tumor
  42. Cytochrome P450 2C19 polymorphism and clopidogrel after MI
  43. Usefulness of N-terminal Pro–Brain Natriuretic Peptide as a Biomarker of the Presence of Carcinoid Heart Disease
  44. Metastatic rectal adenocarcinoma within haemorrhoids: a case report
  45. Periodontal disease in a patient receiving Bevacizumab: a case report
  46. Analysis of 150 Patients With Carcinoid Syndrome Seen in a Single Year at One Institution in the First Decade of the Twenty-First Century
  47. Autoimmune neutropenia following therapy for chronic lymphocytic leukaemia: a report of three cases